Skip to content

Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients

Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients, a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02218398
Enrollment
120
Registered
2014-08-18
Start date
2013-05-31
Completion date
2015-12-31
Last updated
2014-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

airway resistance, lung compliance, Duration of mechanical ventilation

Brief summary

Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.

Detailed description

Bronchodilator is commonly used in mechanical ventilated chronic obstructive pulmonary disease patients. It is assumed that patient's response to bronchodilator is the same during acute exacerbation or when stable whether on mechanical ventilation or not. Decision to treat is often independent of response and the patient's response to the medicine is not precisely evaluated. Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.

Interventions

DRUGAlbuterol

Sponsors

First Affiliated Hospital of Chongqing Medical University
CollaboratorOTHER
Beijing Chao Yang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

should meet all the criteria: 1. Acute exacerbated chronic obstructive pulmonary disease 2. Invasive mechanical ventilation with intubation outside ICU no more than 48 hours

Exclusion criteria

Meet any of the criteria: 1. Asthma 2. Tracheotomy 3. Prolonged Mechanical Ventilation (Have been mechanical ventilated for more than 21 days) 4. Unstable hemodynamic status 5. Severe pneumonia 6. Contraindication for bronchodilator 7. Contraindication for sedation 8. Refusal to participate in study 9. Re-intubation in 48 hours 10. Mental disorder, could not understand and accomplish pulmonary function test

Design outcomes

Primary

MeasureTime frame
Percentage of 12% Decrease in airway resistance30 minutes

Secondary

MeasureTime frame
Duration of mechanical ventilationparticipants will be followed for the duration of ICU stay, an expected average of 28 days

Countries

China

Contacts

Primary ContactJie Li, Master
lijie8497@hotmail.com86-13552976483

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026